ME Therapeutics Closes Over-Subscribed Private Placement
ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”), a publicly listed biotechnology company working on novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer,...

